These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8059798)

  • 21. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of cefotaxime in the treatment of gram-positive pneumonias.
    Jenkinson SG
    Infection; 1985; 13 Suppl 1():S14-7. PubMed ID: 4055045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cefotaxime in bacterial infections.
    Varghese M; Khan AJ; Kumar K; Schaeffer HA; Pierro M; Evans HE
    Clin Pediatr (Phila); 1984 Apr; 23(4):220-2. PubMed ID: 6321080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of intravenous cefotaxime therapy in neonates].
    Nakazawa S; Sato H; Hirama Y; Chikaoka H
    Jpn J Antibiot; 1982 Jul; 35(7):1761-6. PubMed ID: 6294357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of frequency of administration on therapeutic efficacy of cefotaxime.
    Parker RH
    Clin Ther; 1984; 6(4):488-99. PubMed ID: 6088045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
    Torres A; de Celis R; Rabinad E; Marco F; Almela M; Deulofeu R; Rodriguez-Roisin R; Agusti Vidal A
    Chemotherapy; 1989; 35 Suppl 1():15-24. PubMed ID: 2659289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of the efficacy of cefotaxime sodium dosed twice daily. The Swedish experience.
    Bergquist SO; Eriksson I; Eriksson S; Lönnbro N; Runehagen A; Styrud J; Ahlquist G
    Diagn Microbiol Infect Dis; 1995; 22(1-2):163-6. PubMed ID: 7587033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL; Hawkins SH; Sutherland SC
    Am J Med; 1984 Dec; 77(6A):13-6. PubMed ID: 6097117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefmenoxime efficacy, safety, and pharmacokinetics in critical care patients with nosocomial pneumonia.
    Schentag JJ; Reitberg DP; Cumbo TJ
    Am J Med; 1984 Dec; 77(6A):34-42. PubMed ID: 6097122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-centre study to compare meropenem and cefotaxime and metronidazole in the treatment of hospitalized patients with serious infections.
    Mehtar S; Dewar EP; Leaper DJ; Taylor EW
    J Antimicrob Chemother; 1997 May; 39(5):631-8. PubMed ID: 9184363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
    Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical studies of cefotaxime in infections in internal medicine].
    Kawasaki H; Suou T; Watanabe K; Yoshida K; Sasaki H; Kishimoto Y; Sugihara T; Ishitobi S; Kanno S; Tsuruhara I
    Jpn J Antibiot; 1984 Sep; 37(9):1714-28. PubMed ID: 6096586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
    Parish LC; Asper R
    Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
    Höffken G; Pasold R; Pflüger KH; Finke J; Fauser AA; Szelenyi H; Wagner J
    J Antimicrob Chemother; 1999 Sep; 44(3):367-76. PubMed ID: 10511404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors.
    Leroy O; Saux P; Bédos JP; Caulin E
    Chest; 2005 Jul; 128(1):172-83. PubMed ID: 16002932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.